iNeo-Vac-R01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for iNeo-Vac-R01, covering 2026-02-03 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection [Phase 1, Phase 2]